Masataka Tsuge

6.5k total citations
189 papers, 3.9k citations indexed

About

Masataka Tsuge is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Masataka Tsuge has authored 189 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Hepatology, 126 papers in Epidemiology and 24 papers in Molecular Biology. Recurrent topics in Masataka Tsuge's work include Hepatitis C virus research (106 papers), Liver Disease Diagnosis and Treatment (94 papers) and Hepatitis B Virus Studies (78 papers). Masataka Tsuge is often cited by papers focused on Hepatitis C virus research (106 papers), Liver Disease Diagnosis and Treatment (94 papers) and Hepatitis B Virus Studies (78 papers). Masataka Tsuge collaborates with scholars based in Japan, United States and Italy. Masataka Tsuge's co-authors include Kazuaki Chayama, Michio Imamura, Nobuhiko Hiraga, Shoichi Takahashi, Hidenori Ochi, Hiromi Abe, C. Nelson Hayes, Hiroshi Aikata, Daiki Miki and Tomokazu Kawaoka and has published in prestigious journals such as Nature Genetics, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Masataka Tsuge

172 papers receiving 3.8k citations

Peers

Masataka Tsuge
Hidenori Ochi Japan
Georgios Germanidis Greece
Yasuhiro Asahina Japan
Eiji Mita Japan
Tobias Heintges Germany
Seong Gyu Hwang South Korea
Rozanne C. de Veer Netherlands
David Booth Australia
Tung‐Hung Su Taiwan
Pieter E. Zondervan Netherlands
Hidenori Ochi Japan
Masataka Tsuge
Citations per year, relative to Masataka Tsuge Masataka Tsuge (= 1×) peers Hidenori Ochi

Countries citing papers authored by Masataka Tsuge

Since Specialization
Citations

This map shows the geographic impact of Masataka Tsuge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masataka Tsuge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masataka Tsuge more than expected).

Fields of papers citing papers by Masataka Tsuge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masataka Tsuge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masataka Tsuge. The network helps show where Masataka Tsuge may publish in the future.

Co-authorship network of co-authors of Masataka Tsuge

This figure shows the co-authorship network connecting the top 25 collaborators of Masataka Tsuge. A scholar is included among the top collaborators of Masataka Tsuge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masataka Tsuge. Masataka Tsuge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawaoka, Tomokazu, Eisuke Murakami, Takanori Taogoshi, et al.. (2025). Pharmacist intervention through protocol-based pharmacotherapy management is effective to ensure safety in invasive procedures for chronic liver disease. Journal of Pharmaceutical Health Care and Sciences. 11(1). 74–74.
2.
Fujino, Hatsue, Masataka Tsuge, Yasutoshi Fujii, et al.. (2025). Usefulness of serum HBV RNA levels for predicting antiviral response to entecavir treatment in patients with chronic hepatitis B. Journal of Gastroenterology. 60(4). 469–478.
3.
Ono, Atsushi, C. Nelson Hayes, Ryoichi Miura, et al.. (2025). Multiomics Analysis of Liver Molecular Dysregulation Leading to Nonviral-Related Hepatocellular Carcinoma Development. Journal of Proteome Research. 24(3). 1102–1117.
4.
Uchida, Takuro, Masataka Tsuge, Nobuhiko Hiraga, et al.. (2024). Interferon alpha induces a stronger antiviral effect than interferon lambda in HBV/HDV infected humanized mice. Virus Research. 349. 199451–199451.
5.
Tsuboi, Akiyoshi, Hidenori Tanaka, Ken Yamashita, et al.. (2024). Predictive factors of portal hypertensive enteropathy exacerbations based on long-term outcomes. BMC Gastroenterology. 24(1). 287–287.
6.
7.
8.
Fujii, Yasutoshi, Tomokazu Kawaoka, Ryoichi Miura, et al.. (2024). First-Line Durvalumab plus Tremelimumab Treatment for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice. Oncology. 103(8). 742–747. 3 indexed citations
9.
Bao, Hongmei, Masataka Tsuge, Takuro Uchida, et al.. (2024). Alteration of Gene Expression After Entecavir and Pegylated Interferon Therapy in HBV-Infected Chimeric Mouse Liver. Viruses. 16(11). 1743–1743. 1 indexed citations
10.
Fujii, Yasutoshi, Atsushi Ono, C. Nelson Hayes, et al.. (2024). Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma. Cancers. 16(7). 1328–1328. 3 indexed citations
11.
Hayes, C. Nelson, et al.. (2024). From Omics to Multi-Omics: A Review of Advantages and Tradeoffs. Genes. 15(12). 1551–1551. 18 indexed citations
12.
Fujino, Hatsue, Yasutoshi Fujii, Shinsuke Uchikawa, et al.. (2024). Value of autotaxin for hepatocellular carcinoma risk assessment in chronic hepatitis B patients treated with nucleos(t)ide analogs. Hepatology Research. 54(11). 981–992. 1 indexed citations
13.
Yoshida, Osamu, Sheikh Mohammad Fazle Akbar, Yusuke Imai, et al.. (2022). Intranasal therapeutic vaccine containing HBsAg and HBcAg for patients with chronic hepatitis B; 18 months follow‐up results of phase IIa clinical study. Hepatology Research. 53(3). 196–207. 14 indexed citations
14.
Nakahara, Takashi, Masafumi Ono, Takumi Kawaguchi, et al.. (2021). Underestimation of impaired glucose tolerance and usefulness of a continuous glucose monitoring system in chronic liver disease. Journal of Gastroenterology and Hepatology. 37(3). 592–599. 5 indexed citations
15.
Uchikawa, Shinsuke, Tomokazu Kawaoka, Yuwa Ando, et al.. (2020). Trends in Hepatic Functional Reserve of Patients with Hepatocellular Carcinoma Treated with Tyrosine Kinase Inhibitors. Oncology. 98(10). 727–733. 7 indexed citations
16.
Fujino, Hatsue, Mio Tanaka, Michio Imamura, et al.. (2019). Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis. BMC Gastroenterology. 19(1). 169–169. 15 indexed citations
17.
Uchikawa, Shinsuke, Tomokazu Kawaoka, Kenichiro Kodama, et al.. (2019). Skeletal Muscle Loss during Tyrosine Kinase Inhibitor Treatment for Advanced Hepatocellular Carcinoma Patients. Liver Cancer. 9(2). 148–155. 29 indexed citations
18.
Kawaoka, Tomokazu, Hiroshi Aikata, Yuji Teraoka, et al.. (2017). Impact of Hepatitis C Virus Eradication on the Clinical Outcome of Patients with Hepatitis C Virus-Related Advanced Hepatocellular Carcinoma Treated with Sorafenib. Oncology. 92(6). 335–346. 11 indexed citations
19.
Hiraga, Nobuhiko, Hiromi Abe, Michio Imamura, et al.. (2011). Impact of viral amino acid substitutions and host interleukin-28b polymorphism on replication and susceptibility to interferon of hepatitis C virus. Hepatology. 54(3). 764–771. 28 indexed citations
20.
Karino, Yoshiyasu, Itaru Ozeki, Jouji Toyota, et al.. (2011). 1330 IL28B GENOTYPE MAJOR AND RELAPSE OF PREVIOUS PEG-IFN/RBV THERAPY ARE THE CONVINCING PREDICTOR OF SUSTAINED VIROLOGICAL RESPONSE IN TELAPREVIR WITH PEG-IFN/RBV THERAPY. Journal of Hepatology. 54. S525–S525. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hidenori Ochi Breakdown of academic impact, for papers by Georgios Germanidis Breakdown of academic impact, for papers by Yasuhiro Asahina Breakdown of academic impact, for papers by Eiji Mita Breakdown of academic impact, for papers by Tobias Heintges Breakdown of academic impact, for papers by Seong Gyu Hwang Breakdown of academic impact, for papers by Rozanne C. de Veer Breakdown of academic impact, for papers by David Booth Breakdown of academic impact, for papers by Tung‐Hung Su Breakdown of academic impact, for papers by Pieter E. Zondervan
Rankless by CCL
2026